Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Laura Brege Insider Profile
4 Followers
Laura Brege, Director at Pacira Pharmaceuticals, holds 20.48K shares in Portola Pharma (Ticker: PTLA), holds 7.92K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 0.00 shares in ACADIA Pharmaceuticals (Ticker: ACAD).
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+30.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Laura Brege holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 12, 2019 - Sep 12, 2020
Return:+92.00%
The most profitable trade made by Laura Brege
Laura Brege's Trading History
Pacira Pharmaceuticals
Jun 11, 2020
Director
Uninformative Buy
―
$505.36K
Mirum Pharmaceuticals
Sep 12, 2019
Director
Informative Buy
112.20K
$222.50K
ACADIA Pharmaceuticals
Jan 08, 2020
Director
Uninformative Sell
421.90K
$0.00
Dynavax
―
Director
―
$0.00
Portola Pharma
Jun 15, 2020
―
Uninformative Buy
―
$369.16K
Aratana
Jul 30, 2018
―
Uninformative Buy
―
$66.42K
Onyx Pharma
―
―
―
―
Delcath Systems
Jul 09, 2014
Director
Uninformative Buy
―
$196.89K
List of latest transactions for each holding click on a transaction to see Laura Brege's performance on stock
You May Also Like
Laura Brege insider profile FAQ
What is the percentage of profitable transactions made by Laura Brege?
The percentage of profitable transactions made by Laura Brege is 50%.
What is the average return per transaction made by Laura Brege?
The average return per transaction made by Laura Brege is 30.30%.
What stocks does Laura Brege hold?
Laura Brege holds: PCRX, MIRM, ACAD, DVAX, PTLA, PETX, ONXX, DCTH stocks.
What was Laura Brege’s latest transaction?
Laura Brege latest transaction was an Uninformative Buy of ―.
What was Laura Brege's most profitable transaction?
Laura Brege’s most profitable transaction was an Informative Buy of MIRM stock on September 12, 2019. The return on the trade was 92.00%.
What is Laura Brege's role in Pacira Pharmaceuticals?
Laura Brege's role in Pacira Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.